HONG KONG – In vitro diagnostics (IVD) specialist Shanghai Kehua Bio-Engineering Co. Ltd. plans to use new R&D and international sales channels to further its antenatal tests and immunodiagnostics businesses, leveraging the end of China's one child policy into future growth.